Study of LY2157299 in Japanese Participants With Cancer

Clinical trial NCT01722825 · COMPLETED

Trial details

NCT number: NCT01722825
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Neoplasm Metastasis

Start date: 2012-11-01
Primary completion: 2014-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.